HIGHLIGHTS
- who: Manuela Di Fusco from the Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA have published the Article: Impact of COVID-19 and effects of BNT162b2 on patient-reported outcomes: quality of life, symptoms, and work productivity among US adult outpatients, in the Journal: (JOURNAL)
- what: This study evaluated the impact of SARS-CoV-2 infection on symptoms Health-Related Quality of Life (HRQoL) and Work Productivity and Impairment (WPAI) prior to and one month following infection between individuals vaccinated with BNT162b2 and those unvaccinated. Most of the studies assessing humanistic outcomes . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.